Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DORR RT")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1

Export

Selection :

  • and

INAPPARENT INFILTRATIONS ASSOCIATED WITH VINDESINE ADMINISTRATIONDORR RT; JONES SE.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 6; NO 4; PP. 285-288; BIBL. 6 REF.Article

THE CURRENT STATUS OF LAETRILEDORR RT; PAXINOS J.1978; ANN. INTERN. MED.; USA; DA. 1978; VOL. 89; NO 3; PP. 389-397; BIBL. 70 REF.Article

CIMETIDINE ENHANCEMENT OF CYCLOPHOSPHAMIDE ANTITUMOUR ACTIVITYDORR RT; ALBERTS DS.1982; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1982; VOL. 45; NO 1; PP. 35-43; BIBL. 43 REF.Article

PHARMACOLOGIC ANTIDOTES TO EXPERIMENTAL DOXORUBICIN SKIN TOXICITY: A SUGGESTED ROLE FOR BETA-ADRENERGIC COMPOUNDSDORR RT; ALBERTS DS.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1001-1006; BIBL. 31 REF.Article

FAILURE OF DMSO AND VITAMIN E TO PREVENT DOXORUBICIN SKIN ULCERATION IN THE MOUSE = INCAPACITE DU DMSO ET DE LA VITAMINE E DE PREVENIR L'ULCERATION CUTANEE INDUITE PAR LA DOXORUBICINE CHEZ LA SOURISDORR RT; ALBERTS DS.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 499-501; ABS. ENG; BIBL. 17 REF.Article

MODULATION OF EXPERIMENTAL DOXORUBICIN SKIN TOXICITY BY BETA -ADRENERGIC COMPOUNDSDORR RT; ALBERTS DS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 6; PP. 2428-2432; BIBL. 30 REF.Article

BLEOMYCIN COMPATIBILITY WITH SELECTED INTRAVENOUS MEDICATIONSDORR RT; YEI MEIPENG; ALBERTS DS et al.1982; JOURNAL OF MEDICINE (WESTBURY); ISSN 0025-7850; USA; DA. 1982; VOL. 13; NO 1-2; PP. 121-130; BIBL. 1 P.Article

THE LIMITED ROLE OF CORTICOSTEROIDS IN AMELIORATING EXPERIMENTAL DOXORUBICIN SKIN TOXICITY IN THE MOUSEDORR RT; ALBERTS DS; CHEN HSG et al.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 5; NO 1; PP. 17-20; BIBL. 15 REF.Article

EXPERIMENTAL MODEL OF DOXORUBICIN EXTRAVASATION IN THE MOUSEDORR RT; ALBERTS DS; CHEN HSG et al.1980; J. PHARMACOL. METHODS; ISSN 0160-5402; USA; DA. 1980; VOL. 4; NO 3; PP. 237-250; BIBL. 21 REF.Article

INTERACTION OF ALLOPURINOL WITH 6-MERCAPTOPURINE AND AZATHIOPRINEBROOKS JR; DORR RT; DURIE BGM et al.1982; BIOMEDICINE AND PHARMACOTHERAPY; ISSN 512206; FRA; DA. 1982; VOL. 36; NO 4; PP. 217-222; ABS. FRE; BIBL. 20 REF.Article

ALLOPURINOL KINETICS AND BIOAVAILABILITY. INTRAVENOUS ORAL AND RECTAL ADMINISTRATIONAPPELBAUM SJ; MAYERSOHN M; DORR RT et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 1; PP. 93-98; BIBL. 16 REF.Article

POOR RECTAL ABSORPTION OF TRIMETHOPRIM/SULPHAMETHOXAZOLE IN TREATING PNEUMOCYSTIS CARINII PNEUMONIADORR RT; POWELL JR; HEICK M et al.1981; POSTGRAD. MED. J.; ISSN 0032-5473; GBR; DA. 1981; VOL. 57; NO 664; PP. 123-125; BIBL. 8 REF.Article

LIMITATIONS OF A PORTABLE INFUSION PUMP IN AMBULATORY PATIENTS RECEIVING CONTINUOUS INFUSIONS OF ANTICANCER DRUGSDORR RT; TRINCA CE; GRIFFITH K et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 2; PP. 211-213; BIBL. 7 REF.Article

IN VITRO RETINOID BINDING AND RELEASE FROM A COLLAGEN SPONGE MATERIAL IN A SIMULATED INTRAVAGINAL ENVIRONMENTDORR RT; SURWIT EA; DROEGEMUELLER W et al.1982; JOURNAL OF BIOMEDICAL MATERIALS RESEARCH; ISSN 0021-9304; USA; DA. 1982; VOL. 16; NO 6; PP. 839-850; BIBL. 21 REF.Article

SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTIEMETIC IN PATIENTS RECEIVING CANCER CHEMOTHERAPYHERMAN TS; EINHORN LH; JONES SE et al.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 300; NO 23; PP. 1295-1297; BIBL. 17 REF.Article

  • Page / 1